Inqovi 35 MG-100 MG tablet UU 5S
Ended Awarded
- Contract number
- SPE2DB25FW79H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,119
Award facts
- Contract value 100% obligated
- $5,119.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of INQOVI 35 MG-100 MG tablets in unit dose packages of five. This competitively awarded, firm fixed-price delivery order has a ceiling value of $5,119.36 and an ultimate completion date of May 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INQOVI is a prescription medication used in cancer treatment, reflecting the Defense Logistics Agency's ongoing commitment to supplying critical pharmaceuticals for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle that extends through December 2026. As one of the nation's major pharmaceutical distributors, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves as a critical vendor for the Defense Health Agency and other federal healthcare systems. The parent indefinite delivery contract enables the company to fulfill a wide range of pharmaceutical needs across multiple therapeutic domains for military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FW79H?
SPE2DB25FW79H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FW79H worth?
The government has obligated $5,119 on SPE2DB25FW79H.
Is contract SPE2DB25FW79H an order under another contract?
Yes. SPE2DB25FW79H is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW79H competed?
The extent of competition for SPE2DB25FW79H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award